Cargando…

Desmoplasia and Chemoresistance in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) occurs mainly in people older than 50 years of age. Although great strides have been taken in treating PDAC over the past decades its incidence nearly equals its mortality rate and it was quoted as the 4th leading cause of cancer deaths in the U.S. in 2012. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schober, Marvin, Jesenofsky, Ralf, Faissner, Ralf, Weidenauer, Cornelius, Hagmann, Wolfgang, Michl, Patrick, Heuchel, Rainer L., Haas, Stephan L., Löhr, J.-Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276960/ https://www.ncbi.nlm.nih.gov/pubmed/25337831 http://dx.doi.org/10.3390/cancers6042137

Ejemplares similares

Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma
por: Hagmann, Wolfgang, et al.
Publicado: (2010)

Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma
por: Zhao, Xianda, et al.
Publicado: (2016)

Desmoplasia in Pancreatic Cancer. Can We Fight It?
por: Merika, E. E., et al.
Publicado: (2012)

Cellular heterogeneity in pancreatic cancer: the different faces of gremlin action
por: Moustakas, Aristidis, et al.
Publicado: (2022)

3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
por: Longati, Paola, et al.
Publicado: (2013)

Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
por: Gündel, Beate, et al.
Publicado: (2021)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

The complexities of breast cancer desmoplasia
por: Walker, Rosemary A
Publicado: (2001)

Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
por: Lindahl, Anna, et al.
Publicado: (2017)

Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential
por: Cannon, Andrew, et al.
Publicado: (2018)

Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy
por: Ebelt, Nancy D., et al.
Publicado: (2020)

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021)

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015)

Chronic Hyperglycemia Induces Trans-Differentiation of Human Pancreatic Stellate Cells and Enhances the Malignant Molecular Communication with Human Pancreatic Cancer Cells
por: Kiss, Katalin, et al.
Publicado: (2015)

Granular cell ameloblastoma showing desmoplasia
por: Gupta, Suchitra, et al.
Publicado: (2012)

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
por: Kuninty, Praneeth R., et al.
Publicado: (2019)

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
por: Incio, Joao, et al.
Publicado: (2015)

3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
por: Liu, Xinyuan, et al.
Publicado: (2021)

Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
por: Han, Xuexiang, et al.
Publicado: (2018)

Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts
por: Ishii, Norihiro, et al.
Publicado: (2018)

A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
por: Harryvan, T.J., et al.
Publicado: (2022)

Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours
por: Huang, Hsi-Chien, et al.
Publicado: (2022)

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
por: Lankadasari, Manendra Babu, et al.
Publicado: (2018)

Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
por: Willumsen, Nicholas, et al.
Publicado: (2019)

Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer
por: Obaid, Girgis, et al.
Publicado: (2022)

Autophagy in stromal fibroblasts promotes tumor desmoplasia and mammary tumorigenesis
por: Rudnick, Jenny A., et al.
Publicado: (2021)

Assessing the Layer-by-Layer Assembly of Cellulose Nanofibrils and Polyelectrolytes in Pancreatic Tumor Spheroid Formation
por: Abbasi Aval, Negar, et al.
Publicado: (2023)

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
por: Aoki, Shuichi, et al.
Publicado: (2022)

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
por: Wolf, Benjamin, et al.
Publicado: (2023)

Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium
por: Bozóky, Benedek, et al.
Publicado: (2021)

Cortical Anaplastic Ependymoma with Significant Desmoplasia: A Case Report and Literature Review
por: Elsharkawy, Alaa Eldin, et al.
Publicado: (2013)

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
por: Michl, Patrick, et al.
Publicado: (2021)

Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice
por: Johnson, Benjamin L., et al.
Publicado: (2019)

Zinc deficiency in patients with chronic pancreatitis
por: Vujasinovic, Miroslav, et al.
Publicado: (2019)

Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
por: Yang, Zongyuan, et al.
Publicado: (2017)

Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression.
por: Gartner, M. F., et al.
Publicado: (1992)

Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia
por: Suklabaidya, Sujit, et al.
Publicado: (2016)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

Stromal desmoplasia as a possible prognostic indicator in different grades of oral squamous cell carcinoma
por: Zainab, Heena, et al.
Publicado: (2019)

Enhanced Detection of Desmoplasia by Targeted Delivery of Iron Oxide Nanoparticles to the Tumour-Specific Extracellular Matrix
por: Chopra, Meenu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cetf0lvi0sa8pvpd3t500brlc5